| abstract |
ABSTRACT OF THE DISCLOSURE The invention relates to novel pyrrolidinones useful for the treatment of psychic, neurological or neuromuscular disorders, of the general formula: (I) in which: - R1 represents hydrogen or alkyl - R2 represents alkyl, phenyl or trimethylsilyl - R3 represents 2-thienyl or a phenyl possibly substituted once or twice with halogen, methyl, methoxy or a trifluoromethyl group. The novel compounds are formed by hot cyclization of gamma amino ester of formula: (II) or by alkylation in the 3 position of the pyrrolidinone of formula: |